Regulation of mitochondrial homeostasis through retrograde signaling

通过逆行信号调节线粒体稳态

基本信息

  • 批准号:
    10133090
  • 负责人:
  • 金额:
    $ 43.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-04-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Because the majority of mitochondrial proteins are encoded in the nuclear genome, mitochondrial biogenesis and maintenance of mitochondrial homeostasis ultimately depend on nuclear transcription being regulated in response to mitochondrial damage and to changes in cell metabolism or nutrients availability. However, the pathways controlling mitochondria-to-nucleus communication in mammalian cells are still largely unknown. Here, we propose to investigate the hypothesis that the transcriptional cofactor GPS2 regulates mitochondrial homeostasis as a direct mediator of mitochondrial retrograde signaling in mammalian cells with the following Aims: i) Characterize the role of GPS2 in promoting transcriptional activation of nuclear-encoded mitochondrial genes; ii) Dissect the regulation of GPS2 shuttling between mitochondria and nucleus and define the gene programs regulated upon translocation; iii) Elucidate the role of GPS2 retrograde translocation in regulating mitochondrial homeostasis. To achieve these goals, we will use a combination of biochemical techniques, genome wide ChIPseq/RNAseq experiments and open-ended proteomic approaches to dissect the molecular mechanism underlying GPS2-mediated regulation of mitochondrial gene expression in the nucleus and elucidate the regulatory strategies that control GPS2 retrograde translocation both in conditions of mitochondrial stress and during the differentiation of specialized cell lineages. Overall, successful completion of the studies outlined in this application will: 1) identify a novel player in the regulation of mitochondrial gene expression and elucidate the molecular mechanism of its transcriptional activity, 2) dissect the first direct pathway of mitochondrial retrograde signaling in mammalian cells, and 3) reveal an unexpected regulatory strategy for integrating stress and metabolic signaling within the cell through inhibition of non-proteolytic ubiquitination.
项目摘要/摘要 因为大多数线粒体蛋白是在核基因组中编码的, 线粒体生物发生与线粒体动态平衡的最终维持 依赖于线粒体损伤时核转录的调节 以及细胞新陈代谢或营养物质供应的变化。然而,这些路径 在哺乳动物细胞中,控制线粒体到细胞核的通讯在很大程度上仍然是 未知。在这里,我们建议研究一种假设,即转录 辅因子GPS2作为一种直接介导物调节线粒体动态平衡 哺乳动物细胞线粒体逆行信号传递的目的如下:i) 鉴定GPS2在促进核编码基因转录激活中的作用 线粒体基因;II)剖析GPS2在线粒体之间穿梭的调节 和细胞核,并定义了调控易位的基因程序;iii)阐明 GPS2逆行易位在调节线粒体动态平衡中的作用至 为了实现这些目标,我们将使用生物化学技术的组合,全基因组 ChIPseq/RNAseq实验和开放的蛋白质组学方法 GPS2调控线粒体基因的分子机制 并阐明控制GPS2的调控策略 逆行易位在线粒体应激状态和在 特化细胞系的分化。整体来说,研究已顺利完成。 在本申请中概述的将:1)确定线粒体调节的新参与者 基因表达并阐明其转录活性的分子机制,2) 剖析了哺乳动物细胞线粒体逆行信号的第一条直接途径, 以及3)揭示了一种意想不到的整合压力和代谢的调控策略 通过抑制非蛋白水解性泛素化在细胞内传递信号。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Loss of G-Protein Pathway Suppressor 2 Promotes Tumor Growth Through Activation of AKT Signaling.
  • DOI:
    10.3389/fcell.2020.608044
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Chan S;Smith E;Gao Y;Kwan J;Blum BC;Tilston-Lunel AM;Turcinovic I;Varelas X;Cardamone MD;Monti S;Emili A;Perissi V
  • 通讯作者:
    Perissi V
Interaction between poly(A)-binding protein PABPC4 and nuclear receptor corepressor NCoR1 modulates a metabolic stress response.
  • DOI:
    10.1016/j.jbc.2023.104702
  • 发表时间:
    2023-06
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Oliveira, A G;Oliveira, L D;Cruz, M V;Guimaraes, D S P S F;Lima, T I;Santos-Favero, B C;Luchessi, A D;Pauletti, B A;Leme, A P;Bajgelman, M C;Afonso, J;Regitano, L C A;Carvalho, H F;Carneiro, E M;Kobarg, J;Perissi, V;Auwerx, J;Silveira, L R
  • 通讯作者:
    Silveira, L R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VALENTINA PERISSI其他文献

VALENTINA PERISSI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VALENTINA PERISSI', 18)}}的其他基金

Coordination of PAR and Ub signaling in mitochondria
线粒体中 PAR 和 Ub 信号传导的协调
  • 批准号:
    10623889
  • 财政年份:
    2023
  • 资助金额:
    $ 43.83万
  • 项目类别:
Regulation of mitochondrial homeostasis through retrograde signaling
通过逆行信号调节线粒体稳态
  • 批准号:
    9924614
  • 财政年份:
    2018
  • 资助金额:
    $ 43.83万
  • 项目类别:
Ubiquitin-dependent regulation of inflammation and insulin resistance
炎症和胰岛素抵抗的泛素依赖性调节
  • 批准号:
    9243244
  • 财政年份:
    2014
  • 资助金额:
    $ 43.83万
  • 项目类别:
Ubiquitin-dependent regulation of inflammation and insulin resistance
炎症和胰岛素抵抗的泛素依赖性调节
  • 批准号:
    9040938
  • 财政年份:
    2014
  • 资助金额:
    $ 43.83万
  • 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
  • 批准号:
    8328959
  • 财政年份:
    2010
  • 资助金额:
    $ 43.83万
  • 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
  • 批准号:
    8149970
  • 财政年份:
    2010
  • 资助金额:
    $ 43.83万
  • 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
  • 批准号:
    8138837
  • 财政年份:
    2010
  • 资助金额:
    $ 43.83万
  • 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
  • 批准号:
    7300065
  • 财政年份:
    2007
  • 资助金额:
    $ 43.83万
  • 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
  • 批准号:
    7456334
  • 财政年份:
    2007
  • 资助金额:
    $ 43.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了